BioCorteX
PrivateLast Round
Seed
Mar 28, 2023
Total Funding Raised
$5M
Company Overview
BioCorteX is a biotechnology company that operates a techbio platform to model the interactions between the microbiome, host, and treatments to de-risk the pharmaceutical pipeline.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioCorteX Comparables
Compare BioCorteX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Outpost Bio | 84% | |
| Pragma Bio | 78% | |
| QuantHealth | 71% | |
BioCorteX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 28, 2023 |
BioCorteX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hoxton Ventures | Seed |
| Draper Associates | Seed |
| Sofinnova Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 28, 2023
$5M round led by Hoxton Ventures and Sofinnova Partners.
BioCorteX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioCorteX's valuation, stock price, and market status.